We suggest that DDM selectively blocks both glycolysis and OXPHOS pathways and enhances radio-sensitivity in BC cells via the down-regulation of mediators in these processes through PI3K/AKT/mTOR/P53NF-κB/VEGF signaling pathways. The gene discussed is AKT1; the disease is breast cancer.